A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: Sintilimab; Drug: Chemotherapy Sponsors: Fudan University; Innovent Biologics (Suzhou) Co. Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | Research | Skin Cancer | Squamous Cell Carcinoma